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This chapter illustrates the contribution which could be made to realising the Lisbon Strategy 
of the European Union for growth and jobs by innovative healthcare policy favouring a 
preventive orientation of healthcare. The prevention and control of risk factors for chronic 
diseases, as well as their potential impact on the quality of human capital as a union of health 
and education, are discussed. Human capital refers to health and education both of the 
individual, and of the population as a whole. 
 
Investments in health and education could be used to mitigate or compensate the negative 
consequences of demographic change and globalisation. This chapter concentrates on how 
exhausting the prevention potential of chronic diseases could extend the labour force potential 
beyond the conventional age limit of 65 years. Labour force potential usually refers to the 
maximum supply of labour available from workers, the unemployed and other non-workers 
within an age range of 20 to 65 years. This optional innovative policy is explained using the 
example of the development of labour force potential in Germany between 2002 and 2050, 
prerequisites being a change in healthcare policy from cure to prevention, as well as a cultural 
change. Cultural change in the population and in politics would mean attributing the same 
level of importance to the prevention and control of risk factors for chronic diseases as to the 
prevention and control of infectious diseases. 
 
The accumulation of human capital through investments in health and education is crucial to 
the innovative competences of the population. Both these sectors promote growth in the   2 
remaining sectors of the economy and, through their own development, become an essential 
driving force of growth themselves. 
 
The increasing demand for new products and services will create a second health care sector 
for health-related services combining services which are covered by the insurance and by 
private out-of-pocket expenditures. This second sector deals not only with care but also with 
goods and services aside from services covered by the insurance.   
 
Expenditure on health and education therefore has to be included as an investment within the 
national accounts statistics, expanding upon the previous concept of investment. This in turn 
means that corresponding coefficients, for example, would have to be developed for health 
impact assessment purposes. 
 
Expanding labour force potential via compression of morbidity and mortality requires that 
health and education policy be embedded in growth-orientated labour and economic policies 
in order to ensure that the potential working years gained have an impact on production and 
prosperity. Health in All Policies becomes imperative.   
 
 1.   Starting point: the downsides of cost increases and the upsides of growth effects with 
regard to health 
 
In most countries health policy discussions revolve around cost containment. Both the 
Beveridge and the Bismarck systems focus on expenditure development. The OECD regularly 
records and compares per capita health expenditure with regard to gross national product, 
functions and the pharmaceuticals industry [1] The social insurance systems additionally 
include contribution rates, both over time and separately for employers and employees.  
 
Yet regardless of how the healthcare sector is documented and measured in monetary terms, 
whether based on expenditure or contribution rates, no ideal health quota exists. There is no 
practicable conclusion to be deduced using scientific means as to whether a state should spend 
more or less on nursing care, prevention and health promotion. There are good arguments to 
spend more on prevention but at the same time nursing home care of the elderly needs more 
attention too. Bearing this in mind, it is imperative that we put a stop to the traditional 
argument that rising expenditure in healthcare leads to a cost explosion, i.e. that a higher 
percentage of healthcare expenditure with regard to GNP, or higher contribution rates, is 
necessarily a negative thing and that labour costs are fundamentally too high.  
 
In all countries the healthcare allocation is taken from national economic resources, which are 
always marginal. Viewed globally, healthcare has to compete for these resources with climate 
protection measures, education and research expenditure, the safeguarding of pensions, family 
policy and other areas besides. Expenditure in one area amounts to opportunity costs in 
another area.  
 
From this macroeconomic viewpoint, the political decision-making process, coupled with 
market economic processes, leads explicitly or implicitly to the means or resources allocated 
to the healthcare sector within any one country. 
 
Within the healthcare system there is then second-level competition for these resources 
between areas as diverse as prevention and health promotion, curative and emergency 
treatment, rehabilitation, nursing care and palliative medicine, not to forget expenditure for 
statutory sick pay.    3 
 
Focusing on individual patients, it is possible to categorise clinical diagnosis according to the 
International Code of Diseases and population groups e.g. by age and/or sex [2]. From this 
epidemiological perspective the goals of healthcare policy then become avoidable diseases 
and avoidable mortality. On this basis the burden of diseases can be demonstrated.   
 
Finally, insured parties are interested in adequate insurance which in addition to basic cover 
also includes the option of extra individual care 
 
This observation of resource allocation has so far been functional, i.e. independent of 
individual nations or time periods, but there is a more institutional view of the matter which 
also requires consideration. Within each country a comparison is made between the bodies 
occasioning expenditure, e.g. the various branches of a national insurance system, private 
insurance or the individual budgets within healthcare systems financed by tax income. 
 
The results of resource allocation generally attract too little notice, giving rise to a chiefly 
input-orientated view of the matter. This view is gradually becoming replaced by a desire for 
a more output-orientated view. With regard to the healthcare system, this means that the 
resources should be used where they "buy the most health". Ideally, expenditure would then 
have to be repeatedly restructured until the health benefits were equalized across the board. Or 
put another way: expenditure must be cut in those areas where wastefulness and inefficiency 
are greatest. Programme and management-based efficiency increasingly have to replace the 
input orientation which still predominates [3] 
  
Dissolving the input viewpoint based on expenditure or contribution rates throws up a need 
for result indicators. Such indicators are established and compared with the characteristics of 
different national healthcare systems in mind. Here the question arises of how these indicators 
are to be measured, and which ones are to be used for comparison purposes[4]. Upon which 
values and concepts is the selection based anyway: those of epidemiology, medicine, health 
economics or health policy? 
 
In this context there has been a paradigmatic change, taking place in the different countries at 
different points in time and in some still ongoing. This refers not only to the aforementioned 
change away from the cost containment discussion and input viewpoint towards an output-
orientated viewpoint, e.g. avoiding diseases and death or increasing prevention and health 
promotion. We are primarily referring to the fact that healthcare is increasingly being 
acknowledged and classified in positive terms as a labour-intensive growth industry. 
 
This perspective also requires that the selected indicators be substantiated, so that the effects 
of the healthcare sector on the national economy such as value added, employment and 
economic growth are operationalised. Here we are not just concerned with the markets for 
goods and services and the fiscal effects of health, healthcare and health systems, but also 
with the so-called factor markets; i.e. in addition to the money and capital markets, these 
markets especially include the employment markets, with their manifold and new areas of 
occupation within the healthcare sector. 
 
In Germany this discussion began with two reports by the Expert Council for Concerted 
Action in the Healthcare System in 1996/97 [5]. In the second volume the effects of 
healthcare on welfare, growth, productivity and employment were investigated for the first 
time and empirically assessed. In addition, progress in medicine and its various phases was 
addressed, evaluation and health technology assessment, as well as the role of university   4 
hospitals in the progress process and the financing of health-related research. Following an 
analysis of individual examples of medical progress and their respective economic viability, 
selected growth markets were then subjected to a broader exposition. Even back then this 
particularly included nursing care, medical telematics, medical products and the 
pharmaceuticals industry with their individual growth potentials [6]  
 
Ten years later, at least in Germany, the healthcare economy has not only become socially 
acceptable [7], but has also been addressed in its regionalism [8]
1. In 2008 the regional 
healthcare markets are also playing an increasingly significant role in the German 
government's research programme. 
 
Independently of the development in the industrial nations, the macroeconomic significance 
of healthcare investments can be seen within the context of economic development and 
globalisation [9] The EU is also seizing upon this context and is examining the contribution of 
healthcare to the national product of its member states [10] 
 
2.   Theoretical considerations: health as a component of human capital  
 
Discussion about the health economy as a growth industry now not only includes the 
abovementioned linking of health-related investments to growth, but additionally focuses on 
the foreseeable demographic development. Many experts neglect the potentials for growth 
and higher revenues in the face of increasing expectations within a population keen to enjoy 
healthy ageing. Yet healthy ageing as a growth determinant is a topic in itself. 
 
Changes in the disease distribution, are partially linked to demographic developments. In 
particular, an increase in chronic diseases can be observed. Allergies, asthma and diabetes are 
becoming widespread, due in part to ageing, but also to environmental changes [11]. Thus the 
medical treatment and disease management of patients with chronic diseases will increasingly 
substitute the treatment of acute diseases. From a population health view , the challenge of the 
future is the prevention and early diagnosis of chronic diseases. 
 
Considering the changes in demographic development and morbidity structure of the 
population of highly developed countries, a gain in healthy and productive life years will be 
essential in order to maintain a high economic standard. Therefore, it will be necessary not 
only to improve the efficiency of healthcare delivery and financing instruments, but also to 
increase investments in health. As the former EU-Commissioner David Byrne puts it: "Health 
Equals Wealth". This strong relationship led him to consider a health status indicator as a 
new, additional convergence criterion for the expanded European Union [12]. 
 
Given this background, two considerations justify the working hypothesis that there are 
growth and fiscal effects of better health [13]: 
 
An improved health status is an investment in human capital, and alongside (private and 
public) capital and technical progress human capital is one of the three factors which explain 
economic growth and fiscal stability. A healthier population is more productive, and a higher 
functional capacity in an ageing population leads to economically productive life-years. 
Improvements in health and education of the population are thus key factors in promoting 
growth and this also creates better quality of life for citizens. 
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On this basis new markets are opening up, not only in healthcare itself but also in other areas, 
such as wellness and fitness, nutrition etc., through innovative medical and healthcare 
technologies, new products and services. These developments with markets being in the 
center are leading to increasing turnover, higher revenue and growing profits as a basis for 
financing other parts of the economy, including the first health sector. In addition, new 
therapy professions, new study fields and new university research areas are emerging.   
 
As can be seen from a study sponsored by the Robert Bosch Foundation in 2007 [14], 
reference  human capital as a blending of health and education forms one of Germany's most 
important strategic resources. Its quantity and quality decide how the future will be mastered. 
Human capital is one of the most important determinants of economic growth. The 
accumulation of human capital through investments in health and education is crucial for the 
innovative  capacities of a national economy. Both sectors promote the growth of the 
remaining sectors of the economy, and through their own development they themselves 
become an essential source of growth.  
 
Within the union of health and education, health is a prerequisite in the service of education. 
People can only use their human capital effectively if they are healthy and alive. In its Global 
Development Report 2007 [15], the world bank defined investments in human capital via 
health and education as the crucial prerequisite for success in today's competitive globalised 
world, whether as an individual or as an entire economic unit. For most people, employability 
is the only asset which needs to be made permanently more productive in order to sustain and 
continually regenerate prosperity. This means learning to make the correct decisions in order 
to stay healthy and then adhering to them throughout life. With regard to demographic shift 
healthy life expectancy is gaining more and more importance  
    
Health and education "spending" is a term which is often used erroneously when really 
"investment" is meant. Any expenditure which serves to improve effectiveness and create 
future benefits may be counted as an investment. We therefore propose apportioning 
investment spending on health and education so that it appears in the national accounts 
statistics and national budget not as a cost, but as an investment. Spending on health and 
education would then cease to be treated like consumer spending, becoming entirely cost-
effective in the year of consumption and instead, as is customary for investments, would be 
amortised over several years. This would take into account the fact that several years can 
elapse between an investment in health and education and the benefits to be reaped from this 
investment. Similar to the creation of satellite systems alongside the national accounts 
statistics, this development should be promoted for health as a growth factor. According to the 
neoclassical model by [16], increased productivity resulting from technical progress drives on 
economic growth from outside the model – exogenously.  
 
The human capital theory takes into account both microeconomics and macroeconomics and 
was initiated by the Nobel prize-winners for Economics, Schultz 1971 [17] and Becker 1975 
[18]. This theory permits an examination of the prerequisites for determining the economic 
viability of investments in human knowledge and human competence, i.e. in human capital. It 
identifies various paths leading to the creation of human capital, e.g.  
  
•  formal school education,  
•  professional and social educational and vocational training measures and 
•  measures for maintaining and promoting health, such as prevention and health checks. 
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In the 1960s the theoretical model of human capital as an endogenous driving force behind 
growth was developed by Becker 1975 [18], 1993 [19] and then developed further by Mankiw 
et al 1992 [20]. The high significance attributed to human capital compared to fixed capital 
can be observed from a comparison between the proportion of the gross domestic product 
(GDP) invested in fixed capital and in human capital in Germany. 
  
In 2003 the gross fixed capital formation in Germany for equipment, buildings and other 
investments – real capital – amounted to EUR0 384.4 thousand million, corresponding to 
17.8% of the GDP. The true investment rate is much higher, however, taking into account the 
spending on human capital which in the national accounts statistics is included as 
consumption. This expenditure, often commonly called "investment", including by politicians, 
comprises money for education, research and science totalling EUR0 193.9 thousand million 
EUR0 2003, money for art and culture totalling EUR0 0.8 thousand million EUR0 2003 and 
money for health excluding investments and medical research totalling EUR 222.1 thousand 
million EUR 2003. This means a total investment in human capital of 416.8 thousand million 
EUR0 2003 or 19.3% of the GDP in 2003. Table 1 shows the expenditure for real and human 
capital according to the records of the Federal Office for Statistics in 2003 [21] (Statistisches 
Bundesamt). 
 
The "investments" in human capital are thus EUR0 32 thousand million above those in real 
capital. The national economic investment rate is thus 37.1% and not the mere 17.8% 




Table 1: Expenditure for real and human capital in Germany in 2003  
in EUR0, thousand million 
       
 
Gross domestic product (GDP)  2,163.4
Fixed capital 
Total gross fixed capital formation  384.4
Percentage of GDP  17.8
Human capital 
Expenditure education, research, science  193.9
Expenditure art and culture  0.8
Health-related expenditure excl. investments and med. research  222.1
Total human capital  416.8
Percentage of GDP  19.3
 
 
Expanding the concept of investment within the national accounts statistics (SNA) was 
discussed by the United Nations Statistics Division prior to the last update in 1993. Aspen 
[22] then presented the majority opinion of his workgroup, according to which expenditure on 
research and development should also be treated as an investment in the next SNA revision. 
   7 
According to the SNA, expenditure is an investment if it serves to improve effectiveness or 
productivity and if it creates future benefits. Expenditure on research and development was 
attributed these characteristics. In the opinion of the United Nations Statistics Division [22] , 
expenditure on human capital has comparable characteristics to that for research and 
development.  
 
In order to be able to treat expenditure on human capital as an investment in the national 
accounts statistics, the following problems need to be solved: 
 
•  clear criteria for the apportionment of investment spending on human capital 
•  the investment product must be clearly definable 
•  the product must be able to be evaluated in an economically reasonable manner 
•  the amortisation rate of the product must be known. 
     
Despite these unsolved problems, the discussion about classifying spending on human capital 
as an investment will continue. The 1992 Nobel prize-winner for Economics, Gary S. Becker 
[23], advocates that expenditure on education and health be treated as investments in both the 
national accounts statistics and tax. Nordhaus [24] and Cuttler [25] also advocate inclusion of 
health in the national accounts statistics once the methodical problems surrounding this have 
been solved.  
  
Preventive orientation of healthcare and consequently the exhaustion of previously 
unexploited health potential is another as yet unsolved task. According to the latest literature, 
the key to primary prevention is the avoidance of risk factors for chronic diseases, such as 
smoking, unhealthy diet, being overweight or obese, failure to take physical exercise, alcohol 
abuse, and addressing health determinants. Primary prevention is aimed at reducing the 
probability of the onset of chronic and other diseases. According to the latest literature, over 
50% of chronic diseases can be avoided through primary prevention of risk factors.  
 
To date, every significant progressive step related to public health has been connected to 
improve the determinants of health resulting in the reduction and control of risk factors. The 
first significant step was the avoidance of risk factors for infectious diseases in the mid-19
th 
century, notably the observance of rules pertaining to hygiene. The next significant step to 
boost public health will have to be the avoidance of risk factors for chronic diseases [26, 27, 
28].  
 
3.   Overview of existing empirical evidence  
 
One essential reason why hardly any connection, or only a contradictory one, is ascertainable 
between health-related spending and a measurable improvement in health is that health-
related spending is predominantly measured only according to inputs and not outputs. The 
research question which needs to be answered is how growth can be assigned to a specific 
investment health-related outlay. According to provisional estimates by Nordhaus [24], 
consumptive spending on health over the last 50 years has contributed to prosperity to the 
same extent as other consumptive spending. Using the current methods of economic 
evaluation, we are not yet in a position to say whether EUR0 1 spent on health has a return 
which may be EUR0 2, 4 or 10 higher than for that spent on other consumer needs. 
 
The literature reporting microeconomic investigations into investments made by firms in the 
health of their employees is very extensive. Numerous studies in the USA are concerned, for 
example, with health productivity management (HPM). The results of these studies draw a   8 
direct link between the health of employees and their productivity, influencing the profit made 
by the company and ultimately its share price [29] (GOETZEL 1999). Activities are geared 
towards reducing sick-leave costs and increasing productivity by improving the general health 
of staff. Example publications include [30, 31, 32, 33, 34, 35]  
 
Bloom [36] investigated whether at a macroeconomic level there is a correlation between 
health and economic coefficients corresponding to that shown by microeconomic studies. He 
estimated that an increase of 1% in the adult survival rate results in an increase of approx. 
2.8% in labour productivity. In his opinion, health plays a larger role in the promotion of 
economic growth than education.  
 
Sanso [37]examined the connection between life expectancy and growth. In his opinion the 
accumulation of human capital and innovative medical techniques permits individual 
decisions to be made not only about the quality of life, but also about its length. The desire in 
ageing citizens to counteract biological deterioration in order to maintain a high level of 
quality of life will in the future become a driving economic force. Medical science and the 
healthcare economy will provide techniques and products which slow down the loss of quality 
of life through the biological ageing process. The state of health of future generations will 
thus be improved. This will result in increasing individual performance over a longer lifetime, 
inducing economic growth. According to Sanso [37], this growth will generate sufficient 
resources to finance medical research and health-related expenditure.  
 
Cutler [38] conducted a study to investigate the value of health-related spending in the United 
States over a period of 40 years – 1960 to 2000. The increase in life expectancy in the USA 
was compared to the costs of illness and disease. In summary he concluded that over the 
entire 40-year period the cost of one additional year of life expectancy for a newborn baby 
averaged $19,900. For those aged 65 years and over, the same increase over the same period 
cost an average of $84,700. One of his essential conclusions is that 70% of the reason for 
increased life expectancy in newborn babies between 1960 and 2000 is the reduced mortality 
rate resulting from cardiovascular diseases. 
 
According to [38], the current trends with regard to cost development are worrying, however. 
Following his calculation, the cost of one additional year of life expectancy increased 
dramatically in the last two decades of his investigation, especially for the older age groups. 
His analyses to prove an increase in life expectancy for the over-65s show that in the 1970s 
one additional year cost $46,800, whereas by the 1990s this figure had risen to $145,000. The 
rate of increase for health-related spending per year of extended life expectancy is thus 
significantly higher than the rate of increase for years of age. If this trend is sustained, Cutler 
[38] worries that the cost effectiveness of health-related spending for elderly citizens will 
decrease.                     
  
The latest publication on this topic [39] purports the view that investments in health have a 
significant impact on economic development. A good state of health in a population makes a 
crucial contribution to the development of human capital and labour productivity. In the 
opinion of the author, competition is in a position to increase effectiveness, but the state must 
assume responsibility for just financing and access to essential healthcare goods. In 
acknowledging this responsibility, the state could even make a point of increasing health-
related expenditure.   
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4. Macroeconomics and Health 
 
 
The recent Report by the WHO Commission on Macroeconomics and Health, chaired by 
Professor Jeffrey Sachs [40], shows that if world leaders are serious about reducing poverty 
and fostering development, they have to invest in health. And, in its Report, the Commission 
showed how health investments can be managed in order to achieve the best results. 
 
A study of the global figures shows that three avoidable diseases; HIV/AIDS, tuberculosis 
and malaria are overwhelmingly important. Maternal and child conditions, reproductive ill-
health, injuries and the health consequences of tobacco, are also global health priorities. Any 
serious attempt to reduce the disease burden faced by the world’s poorest people must 
concentrate on all these conditions. Any serious attempt to stimulate global economic and 
social development, and so to promote human security, must be successful in addressing the 
burdens caused by AIDS, malaria and TB. 
 
Of the burden caused by the three diseases, HIV/AIDS makes up just over half, both in terms 
of healthy life years lost, and mortality. Malaria and TB share the rest on a roughly equal 
basis. It means that more than 90 Million healthy life years are lost to HIV each year, 40 
million to malaria and nearly 36 million to TB. More than five and a half million lives are lost 
every year to the three diseases alone.     
 
One of the latest documents by the Commission of the European Communities is a 
Commission Staff Working Document accompanying the White Paper: Together for Health – 
A Strategic Approach for the European Union 2008-2013 [41]. It aims to be a cohesive 
framework document, giving clear directions for Community activities in the field of health 
for the coming years, in order to continue to improve and protect health within the EU and 
beyond its borders. It reinforces the importance of health within key EC policies, such as the 
Lisbon Strategy for Growth and Jobs reference , in terms of the links between health and 
economic prosperity, and the Citizen’s Agenda, in terms of people's right to be empowered in 
their health and healthcare. The strategy is a cross-sectoral framework which recognises the 
contribution to health of a wide range of policy areas.  
 
According to the White Paper, there is growing evidence that health contributes to wealth and 
that investment in health contributes to long-term economic growth and sustainability. Health 
policy makers have long been arguing, as mentioned already, that "health means wealth", and 
that a healthy population is necessary for economic productivity and prosperity, not to forget 
that wealth, particularly in the form of effective investment, in turn supports better health.  
 
The strategy argues that health-related costs are considerable in the EU, but effective 
investment in health can lead to more efficient healthcare systems and social security 
schemes, to more people avoiding illness and therefore to greater future financial 
sustainability. As well as healthcare treatment, effective prevention programmes can also 
substantially reduce major and chronic diseases. According to the Commission's White Paper 
there is growing evidence that increased investment in preventive measures could counteract 
the expected growth in health-related costs and expenditure. If the aged population remains 
active and in good health, this is positive both for the individual and for the wider economy. If 
health-specific life expectancy were to evolve, broadly speaking, in line with changes to age-
specific life expectancy, then the projected increase in spending on health due to ageing 
would be halved.  
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In order to maximise the years of age which are healthy and to achieve healthy ageing, it is 
important to promote health and to prevent disease throughout life, including tackling health 
determinants such as diet, physical exercise, alcohol, drug and tobacco consumption, 
environmental and socioeconomic factors. The health of the working population is the key 
factor for economic sustainability. The Community initiatives with regard to health and its 
impact on society support the way we understand and approach health policy, as outlined in 
Chapter 1. Health itself has become a major economic and social driving force in society, as 
described in great detail by Surcke et al [42]. . 
 
An important contribution regarding the correlation between health and the economy has been 
made by [42]. In summary, the authors of this European Commission study conclude that 
investments in health are good for a national economy for the following reasons:  
•  the labour force potential becomes more productive and can generate a higher income 
due to an improved state of health 
•  an improved state of health facilitates a longer working lifetime, a necessity for a 
population which is becoming older and producing fewer children 
•  less sick leave is taken and early retirement becomes less prevalent 
•  greater investments in education pay more dividends in conjunction with an improved 
state of health and a longer working lifetime, contributing to an increase in 
productivity 
•  an improved state of health increases healthy-life expectancy and requires a higher 
savings rate, e.g. as provision for old age, thus generating the means for a higher rate 
of investment.     
 
Surcke [42] examined 65 studies about health in all its various guises and their impact on the 
economy. Overview 1 lists five of these studies in summary.  
The 65 studies, performed using a wide range of analytical methods, are all in agreement with 
the latest literature, stating that the health of a population is the determining factor for personal 
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Table 2: Selected studies from SURCKE 2005 [42] on the correlation 
 between health and the national economy 
 
 
Author Title  Year  End  Points  Conclusion  Publication 
Surcke M, 
Urban D 







Reducing the cardiovascular 
mortality of the labour force 
by 10% causes economic 




for Health and 
Development, 
Venice 
Weil D  Accounting for 




2004  GDP per capita  State of health explains 
19.1% of differences in 
















GDP per capita  A 1% increase in life 
expectancy increases labour 
productivity by 1.7% 











2001  GDP  Health improvements over the 
past 100-125 years increased 
economic growth in 10 




History, Vol. 61, 
No 3, Sept. 
Barro R  Health and 
economic 
growth 
1996  GDP per capita  Increasing life expectancy 
from 40 to 70 years increased 
the growth rate in 100 
countries by 1.4% p.a. 
between 1965 and 1990 
PAHO: 
Programme on 







5. Expanding understanding of health: the first and the second sector for healthcare and 
for health  
 
 
The healthcare sector has developed to become the healthcare economy. Alongside the 
recording of health-related spending, this sector of the economy is interesting from an 
economic and political point of view for its value added and its impact on employment. In 
contrast to other branches of industry and sectors of the economy, the significance of the 
healthcare economy for the national economy has yet to be grasped. Firstly, there is no 
generally acknowledged split up of the healthcare economy within the national accounts 
statistics, the healthcare expenditure calculations and the healthcare staff calculations. This 
situation also leads to very different prognoses regarding the development of the healthcare 
economy. 
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With a qualitative segregation, a first area usually focuses on prevention and the promotion of 
healthy living, curative treatment including care with therapies and medicines, rehabilitation, 
nursing care and palliative medicine. As well as human medicine, this area also includes 
dental medicine, which is treated very differently in different countries as far as the 
remuneration of services is concerned, e.g. Switzerland, New Zealand and Australia on the 
one hand, and France, Germany and the Netherlands on the other. Finally, this area can also 
include sick pay for employees. A first market for healthcare covers this core area, i.e. the 
healthcare sector with all its establishments and providers and remunerable services covered 
by the health insurance companies or a public health service. It also includes all types of extra 
payments, surgery fees or excess payable in times of convalescence.  
 
A second market for health covers an extended range of health-related services and goods 
which are not included in the first market and which are not covered by private or statutory 
health insurance or by a public health service. A more detailed segregation can be made 
according to product, service and business-related characteristics. This area also includes 
"over–the-counter" purchases in chemists or medical supply shops. To date there is no 
uniform segregation between the two areas, i.e. one agreed upon across Europe 
 
Additional criteria for segregation can be deduced from the health benefits to be gained from 
goods and services or from the motivation to buy health-related services and the demand for 
health-related goods. Finally, expenditure for training, research and development must be 
included, each represented proportionally in one of the two markets. A division used in the 
German literature employs the following classes [43]. 
 
•  wholesalers, specialists and retailers, 
•  pharmaceuticals industry, health trade professions, medical technology, biotechnology 
and gene technology, 
•  public administration, health insurance, education, business services, organisation of 
the healthcare economy, research and development, as well as 
•  sport, leisure, wellness, tourism, nutrition and lifestyle. 
  
Even with this division, a subdivision is necessary if the parts belonging to the healthcare 
economy are to be clarified. 
 
In a study by Roland Berger, the authors assume that fitness, wellness, functional food, 
organic foodstuffs and health tourism all belong to the second market for healthcare, albeit to 
different extents [44]. Finally, the international System of Health Accounts also includes 
services which are relevant to health but only indirectly linked with it, e.g. "meals on wheels". 
 
This variety of approaches demonstrates the difficulties involved in agreeing upon a 
segregation, and the growing significance of regional healthcare economy also throws up 
questions regarding a regional segregation of the markets, with their value added and impact 
on employment [45]. 
 
Last but not least, segregation is made even more difficult by the fact that, in the field of 
public health, the relevance of health is increasingly being signalised in all areas of life, e.g. at 
nursery school, at school, at home, at sport, etc.[46]. 
  
In addition to qualitative segregation, questions also arise pertaining to a quantitative 
evaluation of various subdivisions within the healthcare sector. For example, expenditure can 
be divided up according to the occasioners of expenditure and how they are financed,   13 
functionally according to types of service and institutionally according to types of 
establishment. Manpower calculations for the healthcare sector are also determined by the 
type of segregation chosen. In this field the workforce in Germany, for example, fluctuates 
between 4.3 and 4.9 million employees [47].  
 
Against this background of segregating the two markets in different possible ways, 
evaluations of the impact of employment and the value added also differ for the healthcare 
sector.  
 
In one strategy the following proposal has been made for segregating the various areas [48] 
 
•  a core area of strictly healthcare services, restricted to services covered by health 
insurance (Bismarck System) or a public health service (Beveridge System) 
•  an extended area of health-related services covering not only services which are paid 
for privately, but also expenditure on health-related training and research 
•  an area of health-specific intermediate goods and services, to include many medical 
products and characterised by the fact that they are not intended for the end user 
(business to consumer), but for other manufacturers (business to business) 
•  a fourth area covering intermediate goods and services in the healthcare sector not 
specific to health, e.g. facility management in hospitals, canteen services, laundry 
services or new building works.  
 
To summarise, the following overview illustrates the different areas of the healthcare sector 
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6. Labour market implications  
 
In the discussion about segregating the different markets for healthcare, we mentioned not 
only expenditure, value added and the impact on employment, but also healthcare employees. 
According to the calculations of the Federal Office of Statistics, in 2004 10.6% of all 
employees in Germany were working in the healthcare sector. Healthcare employees can be 
divided up into professions, establishments and type of employment.  
 
In addition, we can compare the number of practising physicians per 100,000 inhabitants, 
based on OECD data and calculations by the Federal Office of Statistics.  
 Table 3: Practising physicians 
Year Germany Netherlands Norway Poland Russia  Spain  Sweden Switzerland
Number 
per 100,000 inhabitants 
1980 . 190.72 191.23 . . . 220.20 238.85
1985 . 222.15 220.98 196.76 387.09 . 262.10 273.04
1990 299.57 250.55 248.90 214.18 407.04 . 259.17 298.41
1995 306.53 . 295.26 231.74 385.91 247.39 285.62 316.38
2000 326.04 319.34 292.15 220.02 421.27 316.38 307.34 350.99
2001 330.70 327.82 290.29 224.13 420.37 307.53 283.53 351.41
2002 333.61 338.25 330.49 230.35 425.88 290.94 315.90 355.83
2003 336.75 348.47 338.26 229.39 424.56 322.11 317.95 371.55
2004 339.05 360.37 348.29 224.26 422.09 . 324.57 375.42
2005 340.20 371.30 368.29 . 424.63 . . 389.56
 
 
It should be noted that this comparison ignores important features such as the age structure or 
morbidity of the individual populations, as well as the age structure or employment structure 
(number of full-time, part-time and marginally employed) of the practising physicians. As far 
as new professions in healthcare is concerned, there are some important developments not 
shown in the statistics above [49].  
  
In addition to the two financial advantages for the first healthcare market resulting from the 
expanding second market (see above), other desirable effects are also emerging in the light of 
the demographic development and the many technological innovations. The older population, 
in many countries not suffering from poverty, is demanding new products and services in 
connection with sickness and health, and with this increasing demand for health-related 
services numerous changes are occurring in the many labour markets within the healthcare 
sector.  
 
New vocational training and professional opportunities are changing qualification 
requirements and existing job descriptions, e.g. in nursing, nutritional expertise, management 
and information technology or medical engineering. The physician's assistant, the study nurse, 
the nurse practitioner, the surgical-technical assistant, the orthoptist, the tele-nurse and the 
patient scout are all new occupations, some of which require academic training. These 
positions all serve to guide patients, their families and insured parties more easily through the 
highly complex healthcare system, with its still predominantly sectoral services and their   15 
fragmented financing and intransparent remuneration. Linked to this change there are also 
new areas of work in research and development. 
 
The staff-intensive healthcare field is therefore also a growth industry, with the expansion of 
existing employment opportunities and the development of new job descriptions [50]. Bearing 
this in mind, public discussion about the so-called cost explosion and the linked non-wage 
labour costs needs to be reassessed (see above). The latter can be reduced through new 
financing options, but even an increase in healthcare expenditure financed by wages and 
salaries has a stronger multiplicative effect on growth than rising pension-related expenditure 
[51]. 
 
We have already addressed the impact of the second sector for healthcare on professions 
within the healthcare sector. One peculiarity consists in the fact that these new job 
descriptions cannot usually be obviously assigned to one market or the other. Ambulatory 
nursing services are also individually available, independently of nursing care and health 
insurance stipulations, and physiotherapists, as well as other service providers, are happy to 
do business with patients directly. 
 
Aside from these examples of a financing mix for healthcare services combining insurance 
cover and private payments, and thus of a financing of services from different sources, the 
labour market will experience further innovations. In the light of the current demographic 
development, the rise in chronic diseases and the increasing support required by the elderly in 
this context will lead to increased healthcare expenditure. This concerns not only the 
healthcare services traditionally covered by statutory health and nursing care insurance, but 
also the help required in later life, and thus new services. More and more people are living 
alone and require support at home in order to continue to do so, and in this field the 
abovementioned and other job descriptions will undergo a dynamic development. 
  
A stronger inclusion of non-medical healthcare professions within the healthcare sector means 
that increasing importance will be attached to staff qualifications. In the field of wellness, for 
example, it is becoming increasingly difficult for consumers to differentiate between serious 
providers and less good services. It should be emphasised that there is a real need for quality 
assurance through well-trained staff, especially in conjunction with the care of older and 
geriatric patients – e.g. with degenerative diseases. For this increasingly significant target 
group, dubious and unqualified providers of health-related services can even represent a 
danger to health.  
 
Structures within the vocational training system need to take these developments on board 
flexibly and quickly. This also concerns a redistribution of tasks within a professional world 
which is changing through telecommunication, the alleviation of manual tasks through 
technical intervention, as well as work in new teams.[52]. The telemedical care of patients 
with chronic cardiac insufficiency, and joint data documentation are also part of this new 
development, as well as a new orientation of non-medical fields such as speech therapy, 
physiotherapy, hospital logistics or nursing science in general. Freelancing must also be 
possible. Last but not least, the Internet has meant profound changes to the all-important 
patient-physician relationship [53]. This development shows that the impact of the second 
market for healthcare will means changes in job distribution, as well as a specialisation of the 
services provided and their quality assurance. In the light of this foreseeable development it 
would be desirable to have everyone working with and not against one another. 
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7. On the growth-related effects of health promotion  
 
A good health economics scenario analysis of the potential economic impact of prevention is 
the report by Wanless [54, 55]. The author was requested by the Chancellor of the Exchequer 
to investigate the long-term trends which could shape the British healthcare system (National 
Health Service, NHS) in the next 20 years. His strategy was that healthcare would gain such 
economic significance as to become a dynamic force not only responsible for producing a 
healthy population and a healthy workforce, but also promoting employment and national 
prosperity in its own right. Prevention and a healthy lifestyle would both play major roles. 
Three different strategic scenarios were selected to demonstrate cost development between 
2002 and 2023. 
 
Scenario 1: Solid progress. People become more engaged in relation to their health: life 
expectancy rises considerably, health status improves and people have confidence in the 
primary care system and use it more appropriately. The health service is responsive with high 
rates of technology uptake and a more efficient use of resources. 
Scenario 2: Slow uptake. There is no change in the level of public engagement: life 
expectancy rises by the lowest amount in all three scenarios and the health status of the 
population is constant or deteriorates. The health service is relatively unresponsive with low 
rates of technology uptake and low productivity. 
Scenario 3: Fully engaged. Levels of public engagement in relation to their health are high: 
life expectancy increases go beyond current forecasts, health status improves dramatically and 
people are confident in the health system and demand high quality care. The health service is 
responsive with high rates of technology uptake, particularly in relation to disease prevention. 
Use of resources is more efficient. 
 
Table 4 shows expenditure on healthcare in Britain (National Health Service, NHS) relative to 
GDP for the period 2002 to 2023 according to the three scenarios proposed by Wanless [55]. 
 
Table 4: Expenditure on healthcare in Britain relative to GDP (in %) in three different 
scenarios set out in the Wanless Report 
 
Scenario 2002  2007-  08  2012-13  2017-18  2022-23 
Solid progress  7.7  9.4  10.5  10.9  11.1 
Slow uptake  7.7  9.5  11.0  11.9  12.5 
Fully engaged  7.7  9.4  10.3  10.6  10.6 
 
As is the case with all scenario analyses, the results are sensitive to the assumptions upon 
which they are based. In the "Solid progress" scenario, health-related expenditure relative to 
GDP rises to 11.1% by 2023. Should, however, the increase in productivity within the 
healthcare sector fall just 1% short of that assumed in the scenario, with all other factors 
remaining the same, expenditure relative to GDP would increase to 13.1%. Vice versa, a 1% 
improvement in productivity compared to the assumed level in 2023, with all other factors 
remaining the same, would mean a lower expenditure relative to GDP of 9.4%. This finding 
underlines the necessity of healthcare reforms in order to achieve desired targets.   17 
The scenario "Fully engaged" is the least expensive and yet boasts better results than the other 
two scenarios, not least because of its preventive orientation. According to Wanless [55], the 
state of the population's health would improve by considerably reducing major risk factors 
such as smoking, obesity, poor diet and insufficient physical exercise. The percentage of 
smokers would then be close to that found in California today. Following the assumptions of 
the scenario "Fully engaged", this reduction in risk factors would be at its greatest where they 
are currently to be found most often, namely in the parts of the population with the lowest 
social standing. 
In addition to considerably reducing major risk factors, the scenario "Fully engaged" aims to 
develop from a "system of sickcare" into a "system of healthcare", in which healthy people 
can remain fit and those with chronic diseases can remain as active as possible. The lower 
expenditure resulting from this optimistic scenario compared to the other two is explained as 
follows. 
Spending increases as the result of a growing population with a higher life expectancy making 
more use of out-patient treatment for preventive care and counselling purposes. This is 
counteracted by savings, estimated to be greater than the increase in spending, chiefly 
resulting from a reduction in the prevalence of geriatric diseases and an improvement to the 
general state of health in the population through prevention. Expenditure in scenario 3 "Fully 
engaged" is £30 thousand million or approx. 20% lower for 2023 than in scenario 2 "Slow 
uptake". 
For the growth potential of a national economy, development of the labour force potential, as 
well as the workers activated from this potential in order to generate the GDP, are more 
important than the overall development of the population [56].  
 
The reality in the German labour market is that the average working life ends aged 60. Few 
workers today reach the legally stipulated retirement age of 65 years, which is why the 
average for both men and women is around 60 years. On 01.02.2006 a new law was passed to 
raise the retirement age to 67 years by 2029. It will be raised in gradual steps, starting in 
2012. However, the labour force which is currently actually available has a prevailing age 
range of 20-60 years and disregards the official retirement age of 65, not to mention that of 67 
envisaged for 2029.  
  
This leads researchers to question how prevention-orientated healthcare could succeed in 
raising the real age limit of the labour force potential from its current 60 years to a possible 70 
years by 2050. This extension of employment age to 70 years was recommended, for 
example, by the German Institute for Economic Research in 2005 [57].  
 
Table 5 assumes for its minimum and maximum variants in its 2002 line that the actual age 
limit remains the same between 2002 and 2050, even if a higher retirement age is stipulated 
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Table 5:  Development from 2002 to 2050 of the labour force potential aged 20-60, 20-65, 
20-70 years based on 1000 persons and in accordance with two variants by the Federal 
Office of Statistics 2006 [58] compared to Basis 2002  
   
Variant 1: minimum variant – potential labour force by age group 
  20-60 20-65 20-70 
2002 45,354  45,354  45,354 
2050 29,901  34,834  39,468 
Difference -15,453  -10,520  -5,886 
Variant 2: maximum variant – potential labour force by age group 
2002 45,354  45,354  45,354 
2050 35,240  40,540  45,466 
Difference -10,114  -4,814  112 
 
The column differences for the minimum and maximum variants show how the labour force 
potential would develop by 2050, compared to the baseline year 2002, simply by changing its 
age range from 20-60 years to 20-65 years to 20-70 years. 
 
In the scenario with the minimum variant the labour force potential in the column 20-60 drops 
15.5m persons by 2050.  
  
Increasing the actual age range to 20-65 years would reduce the labour force potential by 
10.5m persons, and a range of 20-70 years would reduce it by just 5.9m.  
  
The maximum variant also assumes in its 2002 line that the actual age limit remains the same 
between 2002 and 2050, even if a higher retirement age is stipulated (20-65, 20-70). In this 
scenario the labour force potential in the column 20-60 years drops 10.1m persons by 2050.  
 
Increasing the actual age range to 20-65 years would reduce the labour force potential by just 
4.8m persons and increasing it to 20-70 years would even induce a slight increase of 0.112m.  
 
Comparing the minimum and maximum variants with the different age limits, the most 
favourable variant – accepting the assumptions of the Federal Office of Statistics – turns out 
to be the combination of a real age range of 20-70 years with the maximum variant for 
population development until 2050. The assumptions of the Federal Office of Statistics 
comprise a slight increase in the birth rate from 1.4 to 1.6 children per woman capable of 
child-bearing, a high life expectancy and a net migration of 200,000 persons per annum. 
Accordingly, in 2050 the labour force potential would still have approximately the same level 
it had in 2002, despite an overall reduction in the population.     
 
Raising the retirement age by law is not in itself enough to achieve a significant increase in 
labour force potential. Without improving the state of health of the population, raising the 
retirement age will primarily induce pension cuts. The labour force potential consists only of 
the population at employable age, e.g. 20-70 years, and contains the subset of workers 
generating the income for non-workers throughout the population and across all age groups.   19 
The process by which the labour force potential is rendered capable of generating the GDP is 
influenced by many factors, of which health is only one. According to SIDDAL 2007, the 
reasons given for early retirement by 55-64-year olds in 15 EU states were health-related in 
up to 25% of cases. In Germany the percentage is 22.9. 
 
According to the report Gesundheit in Deutschland (Health in Germany) [59], chronic 
diseases are the most frequent cause of early retirement and include skeletal, muscular and 
connective tissue disorders; circulatory disorders; psychiatric disorders; and carcinogenic 
diseases. Together these four disease groups were the cause of early retirement in 78% of 
women and 75% of men in 2003.   
 
The, Director of the Office of Behavioral and Social Sciences Research of the National 
Institutes of Health in the USA [60] , ascertained the following in celebration of the 10th 
anniversary of his Office on 15th June 2006: approx. 70% of our state of health is attributable 
to individual, group and social behaviour, representing social determinants.  
It would exceed the scope of this chapter to provide a model calculation for how an actual 
raising of the retirement age and a prevention-orientated healthcare system, achieved through 
investments in human capital and a realisation of the assumptions for increasing labour 
productivity by 2050, could affect economic growth and the financing of income and social 
services. Future investigations into the economic impact of a higher value added potential 
through investments in human capital should address the following theories, to name but a 
few: 
  
•  The social security contribution rates are increasing more slowly than previously 
assumed or not at all since the growing expenditure predicted as a result of 
demographic change and medical progress can be financed by the national insurance 
systems at no extra cost through constant deductions from higher income.  
 
•  With the labour force potential weakened by demographic change, the high stake held 
in world trade by Germany and the EU can still be maintained if labour productivity is 
considerably increased.    
 
•  Because of the high investments in human capital necessary to safeguard a high value 
added potential, if the labour force potential is continually to reproduce it must have at 
its disposal an income which only a highly productive, high-wage economy can 
finance. A high value added potential cannot be guaranteed with low wage levels in 
the long term. 
 
In order to assert itself, a national strategy for growth and jobs requires human capital which 
is equal in quality to the human capital of its competitors, or better still superior. This can 
only be realised by investing in human capital as the union of health and education. Once 
achieved, this then generates a good basis for adopting policies to create a highly productive, 












1.  Health at a Glance 2007, OECD Indicators – ISBN 978-92-64-02732-9 – OECD 2007 
2.  For more details see the "Leading Health Indicators Selected for Healthy People 2010" 
by the US Department of Health and Human Services or the "Main Categories for the 
European Community Health Indicators Set" or the costs of disease, e.g. for Germany 
in 2004, published by the Federal Office of Statistics  
3.  See Zimmermann, H., Henke, K.-D., Finanzwissenschaft, 9th edition, Munich 2005, 
pp.93-108 
4.  For more details see the contribution by Hernandez Aguado in this volume 
5.  Special Report 1996 and Special Report 1997 (both in German), Healthcare in 
Germany, Cost Factor and Future Industry, Vol I: Demography, Morbidity, Economic 
Reserves and Employment, and Vol II: Progress and Growth Markets, Financing and 
Remuneration, Baden-Baden 1996 and Baden-Baden 1997/98 
6.  See also (in German) Neubauer, G., From national insurance to healthcare economy, 
in Adam, H., et.al., eds., Public Finances and Healthcare Economy, Baden-Baden 
2007, pp. 200 
7.  See (in German) The healthcare economy, Das Journal für die Akteure der 
Gesundheitsbranche, Nr. 1, February/March 2008 
8.  See (in German) Henke, K.-D., Cobbers, B., Georgi, A., Schreyögg, J., Berlin's 
healthcare economy – growth and employment prospects, 2nd edition, Berlin 2006; 
Kartte, J., et.al., Innovation and growth in the healthcare system, Roland Berger View, 
Berlin, no year; Hilbert, J., Healthcare metropolis Ruhr, growth opportunities and 
development potential of the healthcare economy, 2005; Healthcare City Berlin e.V., 
ed., Healthcare economy, competences and prospects of the region around the capital 
– a manual, Berlin 2007 
9.  World Health Organization, ed., Macroeconomics and Health: Investing in Health for 
Economic Development, Report of the Commission on Macroeconomics and Health, 
chaired by Jeffrey D. Sachs, Genf 2001 and WHO, Increasing Investments in Health 
Outcomes for the Poor, 2
nd Consultation on Macroeconomics and Health, Genf 2003, 
as well as sowie Pogge, T., Growth and Inequality: Understanding Recent Trends and 
Political Choices, in Dissent Megazine, http://dissentmagazine.org/article/?article=990 
10. European Commission, Health & Consumer Protection, Directorate – General, The 
Contribution of Health to the Economy of the European Union, Luxemburg 2005 
11. Nolte, E., Scholz, R., Shkolmikov, V., Mc Kee, M., The contribution of medical care 
to changing life expectancy in Germany and Poland, Soc Sci Med 2002; 55: 1905-
1921 
12. Byrne, D., Health equals wealth, speech held on the European Health Forum, Bad 
Gastein, 2003, 
http://europa.eu.int/rapid/start/cgi/guesten.ksh?p_action.getfile=gf&doc=SPEECH/03/
443/=/AGED&Ig=EN=type=PDF, download November, 15 2003 
13. See in more detail Henke, K.-D., Health as a Macroeconomic Driver  - The health 
market and its contribution to productivity and economic growth, 9
th European Health 
Forum Gastein 2006, Partnerships for Health 
14. Martin K, Henke KD (200) Gesundheitsökonomische Szenarien zur Prävention, 
sponsored by the Robert Bosch Foundation, Stuttgart 
15. World Bank (2007) World Development Report and the Next Generation. The World 
Bank Group, Washington. 
16. Solow RM (1956) A contribution to the theory of economic growth. Quarterly Journal 
of Economics 70(1) 65-94   21 
17. Schultz TZ (1971) Investment in Human Capital. The Free Press 
18. Becker GS (1975) Human Capital. Chicago University Press, Chicago 
19. Becker GS (1993) Human Capital: a theoretical and empirical analysis, with special 
reference to education, 3
rd edition. The University of Chicago Press, Chicago 
20. Mankiw NG et al (1992) A contribution to the empirics of economic growth. 
Quarterly Journal of Economics 107(2) 407-437 
21. Statistisches Bundesamt (2003) Bevölkerungsentwicklung Deutschlands von 2002 bis 
2050. Ergebnisse der 10. koordinierten Bevölkerungsvorausberechnung, Wiesbaden 
22. Aspen C (1993) Update of the SNA-Issue No. 9 and 10. Issue paper for the meeting of 
the AEG, July 2005. Extending the asset boundary to include research and 
development. United Statistics Division, SNA/M1.05/20 
23. Becker GS (1996) Human Capital : one investment where America is way ahead. 
Business Week, March 11 
24. Nordhaus WD (2002) The Health of Nations: The contribution of improved health to 
Living Standards. Cowles Foundation for Research in Economics, Yale University, 
New Haven 
25. Cutler D, Richardson E (1997) Measuring the health of the US population. Brookings 
Papers on Economic Activity: Microeconomics, 217-271 
26. WHO (2002) The World Health Report. Reducing Risks, Promoting Healthy Life, 
Geneva 
27. WHO (2008) Prevention and control of noncommunicable diseases: implementation 
of the global strategy. Report by the Secretariat, EB122/9, Geneva 
28. Wiener G et al (2003) Multimorbidität in Deutschland. Stand – Entwicklung – Folgen. 
Robert Koch-Institut, Berlin 
29. Goetzel RZ (1999) Employee Health and Productivity. Vice President and Director of 
Consulting and National Practice. The MEDSTAT Group Inc. 
30. Riedel et al (2001) The effect of disease prevention and health promotion on 
workplace productivity: a literature review. Am J Health Promotion, Jan/Feb 
31. Goetzel RZ, Ozminkowski RJ (2000) Health and productivity management: emerging 
opportunities for health promotion professionals for the 21
st century. Am Health 
Promotion, Mar/Apr 
32. Poole SW et al (2001) The impact of an incentive-based worksite health promotion 
programm on modifiable health risk factors. Am J Health Promotion, Sep/Oct 
33. Eriksen MP, Gottlieb NH (1998) A review of the health impact of smoking control at 
the workplace. Am J Health Promotion, Nov/Dec 
34. Grosch JW et al (1998) Worksite health promotion programs in the US: factors 
associated with availability and participation. Am J Health Promotion, Sep/Oct 
35. Heany CA, Goetzel RZ (1997) A review of health-related outcomes of multi-
component worksite health promotion programs. Am J Health Promotion, Mar/Apr 
36. Bloom et al (2002) Health, worker productivity and economic growth. School of 
Public Policy and Management, Carnegie Mellon University, Pittsburgh 
37. Sanso M, Rosa MA (2006) Endogenous longevity, biological deterioration and 
economic growth. Journal of Health Economica, 25/3 555-578 
38. Cutler DM (2006) The Value of Medical Spending in the United States, 1960-2000. N 
Eng J Med 355:920-927 
39. 39 Heller PS (2007) What should Macroeconomists know about Health Care Policy?. 
IMF Working Paper No. 07/13 
40. WHO (no year) Investing in Health. A Summary of the Findings of the Commission 
on Macroeconomics and Health, CMH Support Unit, Geneva   22 
41. European Commission (2007) Commission Staff Working Document accompanying 
the White Paper: Together for Health – A Strategic Approach for the European Union 
2008-2013, Brussels 
42. Surcke M et al (2005) The contribution of Health to the economy in the European 
Union. European Commission, Health and Consumer Protection Directorate-General, 
Luxemburg Office for Official Publications of the European Communities        
43. Hilbert et. al. Rahmenbedingungen und Herausforderungen der Gesundheitswirtschaft, 
Gelsenkirchen 2002 
44. Kartte, J., Neumann, K., Kainzinger, F., Henke, K.-D., Innovation und Wachstum im 
Gesundheitswesen, Roland Berger View, November 2005 
45. See also the individual case study on Berlin's healthcare economy 
46. See Stähl, T., et al., Health in all Policies – Prospects and Potentials, Finnish Ministry 
of Social Affairs and Health, 2006 
47. See Federal Office of Statistics (2006) Gesundheit – Ausgaben, Krankheitskosten und 
Personal 2004, pp. 41, and the study Entwicklungspotentiale der 
Gesundheitswirtschaft in Niedersachsen (2003) BASYS, NIW, pp. 119 
48. Roland Berger Strategy Consultants, Berlin University of Technology (Financial 
Science and Healthcare Economics), BASYS GmbH, Erstellung eines Satellitenkontos 
für die Gesundheitswirtschaft in Deutschland, Forschungsangebot, Berlin 2008, pp. 15 
49. The following section is based on parts of a published text. See Henke, K.-D., Neue 
Berufe im zweiten Gesundheitsmarkt, in Public Health Forum, in press 
50. See also Henke, K.-D., Cobbers, B., Georgi, A., Schreyögg, J., Die Berliner 
Gesundheitswirtschaft – Perspektiven für Wachstum und Beschäftigung, 2nd edition, 
MVW, Berlin 2006 
51. Sachverständigenrat für die Konzertierte Aktion im Gesundheitswesen, 
Sondergutachten 1996, Gesundheitswesen in Deutschland, Kostenfaktor und 
Zukunftsbranche, Vol I: Demographie, Morbidität, Wirtschaftlichkeitsreserven und 
Beschäftigung, Baden-Baden 1996, pp. 235-266 
52. Vgl. Sachverständigenrat Gesundheit (2007): Kooperation und Verantwortung – 
Voraussetzungen einer zielorientierten Gesundheitsversorgung, Bonn, S. 137 sowie 
Höppner, K., Stärkere Einbeziehung nicht-ärztlicher Gesundheitsberufe in die 
Gesundheitsversorgung, in: Die Ersatzkasse, Heft 10/2007, S. 393-396 aber auch 
Rabbata, S., „Ärztliche Verantwortung ist nicht teilbar“, in Deutsches Ärzteblatt, Jg. 
104, Heft 44, 2. November 2007, S. A 2988 sowie Lohmann, H., Lohfert, Chr., 
Medizin im Zentrum des Umbruchs. Erfolgsfaktoren im Überlebenskampf der 
Krankenhäuser, Hamburg 2007 
53. Siehe Henke, K.-D., Zehn Thesen zur Arzt-Patienten-Beziehung aus 
gesundheitswirtschaftlicher Sicht, in: Schumpelick, V., Vogel, B., Hrsg., Arzt und 
Patient. Eine Beziehung im Wandel, Freiburg im Breisgau 2006, S. 115-124 
54. Wanless D (2002) Securing our future health: taking a long-term view. Final Report. 
The Public Enquiry Unit, HM Treasury, Parliament Street, London 
55. Wanless D (2004) Securing Health for the Whole Population. Final Report, HM 
Treasury, London  
56. Deutsche Bank Research (2003) Aktuelle Themen, Demografie Spezial. Deutsches 
Wachstumspotenzial: Vor demographischer Herausforderung, Nr. 277, Frankfurt am 
Main  
57. Deutsches Institut für Wirtschaftsforchung (2005). Handlungsbedarf. ZDF und 
Tagesspiegel 
58. Statistisches Bundesamt (2006) Bevölkerungsentwicklung Deutschlands bis 2050. 
Ergebnisse der 11. koordinierten Bevölkerungsvorausberechnung, Presseexemplar, 
Wiesbaden   23 
59. Gesundheit in Deutschland (2006) Kommission Gesundheitsberichtserstattung, 
Abteilung Epidemiologie und Gesundheitsberichtserstattung des Robert Koch 
Instituts, Gruppe Gesundheit des Statistischen Bundesamtes. Gesundheit in 
Deutschland – Gesundheitsberichtserstattung des Bundes, Berlin 
60. Abrams D (2006) Office of Behavioral and Social Sciences, National Institutes of 
Health 
 
                
 
Berlin's healthcare market as a driving economic force: 
A regional case study 
 
Executive Summary 
Berlin's healthcare economy is a continually growing market with potentials which are 
increasingly attracting attention. The following is an endeavour to demonstrate the 
significance of Berlin's healthcare market as a branch of industry, using quantitative 
parameters. Trends and structural changes over the last few years are particularly visible in 
the development of turnover and employment. The prospects for growth and employment in 
Berlin's healthcare economy become especially clear in a comparison with other branches of 
industry. Against this background it is important that Berlin be expanded as a centre of 
science, industry and medical care
2.  
1. Turnover and gross value added of Berlin's healthcare market  
A market analysis of Berlin as a healthcare region requires not only an analysis of the demand 
for health-related services, but also an examination of its supply structures. The baseline 
economic situation can be characterised using two coefficients – turnover and gross value 
added. The overall turnover of Berlin's healthcare market is the sum of the turnover of all its 
submarkets. In 2004 this was approx. EUR 14.1 thousand million, 19.8% higher than the 
turnover in 2000, totalling EUR 11.8 thousand million. The supply side results from a 
division of Berlin's healthcare economy into seven different submarkets, each with its 
respective turnover (cf. Fig. 1). A clear observation is that industry, i.e. the medical 
technology industry and the pharmaceuticals industry, is responsible for more than half the 
growth, followed by the hospitals, retail and trade, as well as ambulatory care. Fig. 1 also 
shows the turnover development of the individual submarkets compared to 2000. 
    
In addition to turnover, a second output compilation coefficient describing the performance 
of a national economy is gross value added. If the intermediate goods and services which 
occur in the creation of products and services are deducted from the overall turnover, the 
result is the gross value added and thus the contribution of a branch of industry to the gross 
national income of an individual economy. However, the concessions are difficult to quantify 
due to their intersectoral and intrasectoral overlap. Because of this, in 1996 the Committee of 
Experts for the Concerted Action in Healthcare assumed a 40% deduction when evaluating 
gross value added for the German healthcare market [1], [2]. Following the assumption that 
the production structure with regard to production levels and concessions across the whole of 
Germany cannot be so different from that in Berlin, this figure can be transferred for our 
                                                 
2 This case study has already appeared in German. See Georgi, A., Henke, K.-D., Die Berliner 
Gesundheitswirtschaft: Zahlen, Daten, Fakten, Strategien, in: Gesundheitsstadt Berlin e.V:, ed., Handbuch 
Gesundheitswirtschaft, Kompetenzen und Perspektiven der Hauptstadtregion, Berlin 2007, pp. 498 - 503   24 
purposes. For 2004 this means an estimated gross value added of approx. EUR 8.5 thousand 
million for Berlin's healthcare economy. This in turn corresponds to 11.6% of the gross value 
added for all areas of Berlin's economy in the same year. In comparison, healthcare across the 
whole of Germany is only responsible for approx. 4 to 5% of gross value added [1], [2], [3]. 
In view of the higher density of healthcare establishments in urban regions, the figure 
evaluated for Berlin comes as no surprise; indeed, it illuminates the considerable importance 
of the healthcare market in Berlin. 
 
The growth of the healthcare market reflects a shift in consumer preferences, with the 
increased use of health-related services frequently corresponding to an increased need for 
services. It should not be ignored, however, that the effect on demand of altered preferences 
for health-related services is probably very distorted due to tight regulation. A growing 
healthcare market strengthens the growth of a society and should therefore be regarded as 
positive, as long as the rising non-wage labour costs resulting from increasing health 
insurance premiums do not represent a regionall disadvantage.  
2. Health-related spending in the capital 
The increase in health-related spending means a wealth of new jobs in related areas. This 
trend is also noticeable in Berlin (cf. section 3). The exact expenditure for healthcare in the 
capital has not been explicitly identified, however. The figure can be estimated by taking into 
consideration the calculation made by the Federal Office of Statistics for health-related 
spending in 2003, whereby the statutory and private health insurance companies were 
together responsible for 65.4% of national healthcare expenditure in Germany [4]. Taking the 
expenditure of the statutory and private health insurance companies in Berlin as a basis, 
namely EUR 5.1 thousand million, and assuming that this sum represents 65.4% of Berlin's 
health-related spending, it follows that total expenditure would be EUR 7.9 thousand million. 
This means that, in total, an estimated EUR 7.9 thousand million is spent in Berlin by the 
various occasioners of health-related expenditure on services, premiums and other payments.  
  
In 2004, Berlin's gross domestic product was EUR 77.9 thousand million, approx. 10.1% of 
which was health-related expenditure [5]. Compared with the national average for health of 
10.6% in 2004, Berlin's spending in this area would be slightly less according to this estimate. 
Taken alongside the comparatively high value added percentage for the healthcare economy 
on the supply side, this indicates a relatively high external demand (national and 
international). 
3. Employment potential in the Berlin region 
Employment in Germany's national economy is influenced by the healthcare economy in three 
different ways. By providing health-related services, this sector improves human capital and 
thus helps to increase productivity [1], [6]. Since in the German healthcare system employers 
participate in premium payments through their employers' contribution and thus also in the 
financing of the statutory health insurance system, its development therefore also affects the 
level of non-wage labour costs. Finally, a large proportion of employees paying national 
insurance work in the healthcare sector. For 2004 the Federal Office of Statistics calculated 
4.2m employees in health-related areas (healthcare workers and their jobs). In Germany one 
in nine persons in active employment works in the healthcare sector. 
 
The picture in Berlin is slightly different. Data from 2004 show approx. 180,000 persons 
employed in health-related areas, corresponding to 11.7% of the population, or one in eight   25 
persons in the capital in active employment [7]. Whereas in Germany approx. 67% of the 
actively employed work in service occupations, in Berlin the figure for this sector is 84.6%. 
Since the healthcare market can predominantly be characterised as a service market, these 
figures illustrate the importance of the healthcare market for Berlin's labour market (cf. Fig. 
2). The ambulatory field in particular, including dental surgeries, psychotherapists, 
ergotherapists, speech therapists, homeopathic practitioners, etc., etc., is the most prominent 
employer in Berlin's healthcare market, totalling 52,281 employees. The hospitals come in 
second, with 39,792 employees, and out-patient and in-patient nursing homes and services 
employ a total of 29,791 persons. It should be noted here that many citizens within Berlin's 
healthcare economy work on a voluntary basis, e.g. in hospices. A lack of data means that 
they cannot be quantitatively accounted for, however (cf. Fig. 3).  
4. Monitoring growth and employment in Berlin 
Following this analysis of turnover and employment, the two coefficients can now be 
represented in context using monitoring techniques. This presupposes that sufficient data from 
different points in time are available in order to demonstrate a potential trend. In Fig. 4 one 
point represents a submarket for a particular year with the coordinates turnover and 
employment. 
  
Worthy of notice is the pronounced horizontal development of the pharmaceuticals industry in 
Berlin. The employment rate in this submarket has hardly changed at all since 1995, and yet 
the turnover has more than doubled. Similar developments can be seen for the pharmacies. A 
different trend can be observed for in-patient nursing care. Here the development is vertical, 
i.e. employment increased while the turnover remained more or less the same. In contrast, 
out-patient care experienced remarkable movements in both employment and turnover 
between 1997 and 2004. The analysis of growth and turnover in Berlin's healthcare economy 
is a good instrument for visualising trends (cf. Fig. 4). 
5. Berlin – an expanding healthcare metropolis  
Progress in medical technology, coupled with our demographic development, will lead to an 
increased requirement for personnel, especially in nursing care and out-patient medical care 
[7], [8]. The high density of science and vocational training, industry and hospitals in Berlin 
additionally provides favourable regional conditions. Centres of competence and care 
networks are developing. Berlin's healthcare economy as a staff-intensive branch of the 
services industry is very high-tech, boasting a thriving pharmaceuticals industry, medical 
technology, biotechnology and gene technology, as well as research into medical care, 
information technology, consulting and software services.  
 
Complementing the "Healthcare Region Berlin-Brandenburg" master plan, the conclusions 
and recommendations drawn from the study "Berlin's Healthcare Economy" and the 
comparable study for Brandenburg should support political decision-making in the future [7], 
[9]. Among other things, this would also mean access to an analysis of strengths and 
weaknesses or a comparison of regional advantages and disadvantages for potential providers, 
which would make it easier to draw up concepts for developing Berlin's healthcare market 
further. 
 
For example, healthcare technologies could be marketed internationally with the label "Made 
in Berlin" [7], [10]. Healthcare brand names will become increasingly important in Germany. 
Sustained growth is, however, only possible if an intelligent political framework can be put   26 
into place. With regard to regional competition, national powers should distance themselves 
even more from the provision of healthcare services: what is needed right now is more market 
and a strong state. The state needs to enforce the economic rules of play, but should then 
refrain from interfering in the game. 
 
Fig. 1 Comparison of turnover for Berlin's healthcare economy submarkets between the years 2000 

























∑ 11,8 bn €
Turnover 2004: 
∑ 14,1 bn € 2,729
 
 
Source: Henke K-D, Cobbers B, Georgi A, Schreyögg J (2006), Die Berliner 
Gesundheitswirtschaft – Perspektiven für Wachstum und Beschäftigung, 2nd edition, Berlin 
2006, p. 95. 
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Source: Henke K-D, Cobbers B, Georgi A, Schreyögg J (2006), Die Berliner 














Healthcare economy: 179,777 (11.7 %)
Total number of actively employed:  1,533,500  28 
Fig 3 Comparison of employment rates in the submarkets of Berlin's healthcare economy 
between 2000 and 2004 
 
     Source:  Henke  K-D,  Cobbers  B,  Georgi A, Schreyögg J (2006), Die Berliner 
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Total employment 2004: 179,777     11.7% of Berlin’s gainfully employed   29 
 
 
Fig. 4 Development of growth and employment in Berlin's healthcare economy  
 
Source: Henke K-D, Cobbers B, Georgi A, Schreyögg J (2006), Die Berliner 
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